VivoSim Labs (VIVS) Interest Expenses (2011 - 2026)
VivoSim Labs (VIVS) posted quarterly Interest Expenses of $4000.0 for Q1 2026, up 101.06% year-over-year from $1989.5 in Q1 2025, and down 97.04% quarter-over-quarter from $135000.0 in Q4 2025.
VivoSim Labs (VIVS) Interest Expenses (2011 - 2026) Analysis & Trends
VivoSim Labs' Interest Expenses history runs 16 years deep, the most recent figure standing at $4000.0 for Q1 2026.
- In Q1 2026, Interest Expenses rose 101.06% year-over-year to $4000.0; the TTM figure through Mar 2026 stood at $407000.0 (up 3970.0% YoY), while the FY2026 annual figure was $3.0 million, up 6.77% from the prior year.
- Interest Expenses for Q1 2026 stood at $4000.0, down from $135000.0 in the prior quarter.
- The five-year high for Interest Expenses was $183000.0 in Q1 2022, with the low at -$379000.0 in Q1 2025.
- The 5-year median for Interest Expenses is $126000.0 (2023), against an average of $90470.6.
- The sharpest annual moves came in 2023 and 2025: Interest Expenses surged 111.86% in 2023, then slumped 387.12% in 2025.
- VivoSim Labs' Interest Expenses stood at $59000.0 in 2022, then soared by 111.86% to $125000.0 in 2023, then grew by 3.2% to $129000.0 in 2024, then grew by 4.65% to $135000.0 in 2025, then slumped by 97.04% to $4000.0 in 2026.
- Business Quant data shows VIVS's Interest Expenses at $4000.0 in Q1 2026, $135000.0 in Q4 2025, and $134000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - | 4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 322,000.00 |
| Jun 30, 2026 | 322,000.00 |
| Mar 31, 2026 | 4,000.00 |
| Mar 31, 2026 | 4,000.00 |
| Dec 31, 2025 | 135,000.00 |
| Dec 31, 2025 | 135,000.00 |
| Sep 30, 2025 | 134,000.00 |
| Sep 30, 2025 | 134,000.00 |
| Jun 30, 2025 | 134,000.00 |
| Jun 30, 2025 | 134,000.00 |
| Mar 31, 2025 | -379,000.00 |
| Mar 31, 2025 | -379,000.00 |
| Dec 31, 2024 | 129,000.00 |
| Dec 31, 2024 | 129,000.00 |
| Sep 30, 2024 | 130,000.00 |
| Sep 30, 2024 | 130,000.00 |
| Jun 30, 2024 | 130,000.00 |
| Jun 30, 2024 | 130,000.00 |
| Mar 31, 2024 | 132,000.00 |
| Mar 31, 2024 | 132,000.00 |